Gemini Therapeutics, Inc. ($GMTX)
Filing Information
| Accession Number | 0001193125-26-047193 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 10, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
42,500
Total Value
$0.00
P&L
+inf% (+$57,375.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 10, 2026 | Grant/Award | 17,000 | $0.00 | $0.00 | 95,845 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Feb 10, 2026 | Grant/Award | 25,500 | $0.00 | $0.00 | 25,500 | Direct | โ | View Details |